Kaya Holdings (KAYS) Revenue Growth (3y) (2017 - 2025)
Kaya Holdings (KAYS) Revenue Growth (3y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 2.84% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 4.19% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 15.52% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 14.49% |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 24.66% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 2.94% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -48.41% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 7.85% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 47.17% |
| 10 | Kaya Holdings | - | - | 5,370.00 | -68.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -68.50% |
| Jun 30, 2025 | -62.74% |
| Mar 31, 2025 | -66.56% |
| Dec 31, 2024 | -28.45% |
| Sep 30, 2024 | -75.89% |
| Mar 31, 2024 | -50.93% |
| Dec 31, 2023 | -48.98% |
| Sep 30, 2023 | -40.13% |
| Jun 30, 2023 | -40.67% |
| Mar 31, 2023 | -41.03% |
| Dec 31, 2022 | -23.97% |
| Sep 30, 2022 | -6.09% |
| Jun 30, 2022 | -7.81% |
| Mar 31, 2022 | -10.57% |
| Dec 31, 2021 | -11.32% |
| Sep 30, 2021 | -11.03% |
| Jun 30, 2021 | -6.34% |
| Mar 31, 2021 | -2.45% |
| Dec 31, 2020 | -5.10% |
| Sep 30, 2020 | -5.02% |